Cui, T., Gray, A., Hlavin Bell, E., McElroy, J., Geurts, M., Meng, W., . . . Chakravarti, A. (2018). CSIG-24. miR-575 IS ASSOCIATED WITH WORSE SURVIVAL OF GBM PATIENTS AND ACTS AS A NOVEL ONCOGENE THROUGH TARGETING p27/CDKN1B AND BLID/BRCC2. Neuro Oncol.
استشهاد بنمط شيكاغوCui, Tiantian, Ashley Gray, Erica Hlavin Bell, Joseph McElroy, Marjolein Geurts, Wei Meng, Jahar Haque, Pierre Robe, و Arnab Chakravarti. "CSIG-24. MiR-575 IS ASSOCIATED WITH WORSE SURVIVAL OF GBM PATIENTS AND ACTS AS A NOVEL ONCOGENE THROUGH TARGETING P27/CDKN1B AND BLID/BRCC2." Neuro Oncol 2018.
MLA استشهادCui, Tiantian, et al. "CSIG-24. MiR-575 IS ASSOCIATED WITH WORSE SURVIVAL OF GBM PATIENTS AND ACTS AS A NOVEL ONCOGENE THROUGH TARGETING P27/CDKN1B AND BLID/BRCC2." Neuro Oncol 2018.